Key Votes

Chamber

Keyword Search

Search string must be longer than 3 characters.

Vote Smart provides easy access to congressional and state voting records and maintains a collection of key votes grouped by issue. Vote Smart uses the following criteria to select key votes:

  1. The vote should be helpful in portraying how a member stands on a particular issue
  2. The vote should be clear for any person to understand
  3. The vote has received media attention
  4. The vote was passed or defeated by a very close margin
  5. Occasionally, if a specific bill is consistently inquired about on the Voter's Research Hotline, the vote will be added

Vote Smart provides a summary of the version of the bill text associated with each selected key vote. Our summaries are written by Vote Smart's staff and interns, who adhere to our strict policies and procedures in order to guarantee absolute impartiality and accuracy. They do not necessarily reflect the content of the final version of the bill, but rather the version voted on in that stage. While many procedural votes take place before a full chamber vote, our voting stages reflect the final reading of each chamber vote. Each key vote selection is reviewed by the project's community of advisors, who are political scientists and journalists from all fifty states.

For more information about the legislative process, see here.


results per page:
Date State Bill No. Title Outcome
Dec. 13, 2023 PA SB 683 Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests Bill Passed - House (166 - 37)
Dec. 12, 2023 National HR 4531 Support for Patients and Communities Reauthorization Act Bill Passed - House (386 - 37)
Oct. 5, 2023 MI SB 179 Authorizes Native American Tribes and the State to Form Individual Regulations and Taxes for Cannabis Bill Passed - House (91 - 15)
Sept. 19, 2023 NC SB 189 Amends Legal Classification and Penalties for Crimes Related to Fentanyl Distribution Bill Passed - House (81 - 20)
Sept. 12, 2023 CA SB 326 Authorizes Counties to Provide Substance Abuse Disorder Treatment that Emphasizes Housing Bill Passed - House (68 - 7)
Sept. 6, 2023 CA SB 58 Amends Laws and Statutes Concerning the Decriminalization of Certain Hallucinogens Bill Passed - House (43 - 15)
June 30, 2023 NJ S 1615 Establishes an Independent Board of Experts to Guide the State on Prescription Drug Policy Bill Passed - House (55 - 20)
June 24, 2023 OR HB 2395 Authorizes Specified Persons to Distribute and Administer Short-Acting Opioid Reversal Drugs and Kits Concurrence Vote Passed - House (46 - 3)
June 8, 2023 LA HB 90 Increases Penalties for Drug Distribution Resulting in Death to Life in Prison Conference Report Adopted - House (78 - 19)
June 5, 2023 NV SB 277 Expands the Amount of Legal Cannabis Individual's Can Possess Bill Passed - House (28 - 14)
June 3, 2023 NV AB 322 Establishes Regulations for Kratom Usage and Possession Bill Passed - House (30 - 12)
May 31, 2023 LA SB 49 Establishes New Penalties for the Operation of a Fentanyl Producing Laboratory Bill Passed - House (93 - 4)
May 31, 2023 NV AB 232 Establishes New Rules Regarding Premium Tobacco Products Bill Passed - House (35 - 7)
May 29, 2023 NV SB 35 Increases Criminal Penalties for Fentanyl Trafficking and Possession Bill Passed - House (31 - 10)
May 26, 2023 OK SB 437 Authorizes the Oklahoma Medical Marijuana Authority to Select a Vendor for Seed-to-Sale Inventory Tracking Concurrence Vote Passed - House (72 - 20)
May 25, 2023 OR SB 1043 Requires Hospitals to Provide Narcan Bill Passed - House (44 - 10)
May 25, 2023 National HR 467 HALT Fentanyl Act Bill Passed - House (289 - 133)
May 25, 2023 CA AB 461 Requires Fentanyl Test Strips and Education about Use on College Campuses Bill Passed - House (78 - 0)
May 23, 2023 LA HB 286 Authorizes Expungements for Certain Amounts of Possession of Marijuana Bill Passed - House (69 - 30)
May 17, 2023 MN SF 2744 Establishes New Protections Over Prescription Drug Costs Conference Report Adopted - House (69 - 59)
May 16, 2023 WA SB 5536 Establishes Possession of a Controlled Substance as a Gross Misdemeanor (83 - 13)
May 16, 2023 AK HB 112 Amends Requirements for Epinephrine Prescription Bill Passed - House (36 - 4)
May 12, 2023 MO HB 202 Amends State Industrial Hemp Regulations Concurrence Vote Passed - House (105 - 47)
April 27, 2023 IN SB 8 Authorizes Pharmacy Benefit Managers to Negotiate Prices for Drugs Conference Report Adopted - House (72 - 21)
April 26, 2023 MT SB 442 Authorizes Counties to Use of 20% of Cannabis Revenues for Construction and Repair of Rural Roads Bill Passed - House (82 - 17)
April 25, 2023 MN HF 100 Establishes Cannabis Policy and Finances Bill Passed - House (71 - 59)
April 25, 2023 NV AB 250 Reduces Prescription Drug Costs by Expanding Policies Under the Federal Inflation Reduction Act Bill Passed - House (27 - 15)
April 13, 2023 OR HB 2513 Requires the Oregon Health Authority Carry Out State Voter Approved Drug Decriminalization Law Bill Passed - House (49 - 3)
April 12, 2023 VA SB 903 Authorizes New Limits on the THC Amount in Hemp Products Concurrence Vote Passed - House (52 - 41)
April 12, 2023 VA SB 1337 Establishes New Regulations and Provisions to the Medical Marijuana Program Concurrence Vote Passed - House (74 - 20)
April 12, 2023 VA SB 1533 Requires the Board of Pharmacy Consider Certain Factors when Determining Additional Cultivation Locations Concurrence Vote Passed - House (78 - 16)
April 12, 2023 WA SB 5069 Authorizes Interstate Cannabis Agreements Bill Passed - House (71 - 26)
April 10, 2023 MD SB 516 Authorizes an Independent Maryland Cannabis Administration Bill Passed - House (102 - 35)
April 8, 2023 MD HB 556 Requires Legalization of Recreational Cannabis by July 1, 2023 Concurrence Vote Passed - House (104 - 35)
April 7, 2023 KS SB 174 Exempts and Decriminalizes Fentanyl Testing Strips from the List of Drug Paraphernalia Conference Report Adopted - House (113 - 9)
April 6, 2023 NH HB 639 Authorizes Adults 21 and Older to Possess up to 4 Ounces of Cannabis Bill Passed - House (272 - 109)
March 30, 2023 KY SB 47 Establishes Legal Medical Cannabis Bill Passed - House (66 - 33)
March 29, 2023 GA HB 557 Authorizes Certain Physicians to Prescribe Schedule 2 Controlled Subtances Concurrence Vote Passed - House (173 - 2)
March 21, 2023 IA HF 595 Increases Penalties for the Manufacture, Distribution and Possession of Drugs Containing Fentanyl Bill Passed - House (91 - 3)
March 17, 2023 NM SB 51 Authorizes Cost-Sharing Contributions for Prescription Drug Bill Passed - House (44 - 21)
March 10, 2023 WV SB 220 Establishes the Industrial Hemp Development Act Bill Passed - House (92 - 4)
March 9, 2023 DE HB 2 Establishes State Regulations and Taxes for Recreational Cannabis Bill Passed - House (27 - 13)
March 7, 2023 DE HB 1 Authorizes Recreational Cannabis Use for Adults 21 and Older Bill Passed - House (28 - 13)
March 6, 2023 SD SB 1 Expands Definition of Who Can Access Medical Marijuana Program Bill Passed - House (36 - 32)
March 6, 2023 SD SB 1 Expands Definition of Who Can Access Medical Marijuana Program Bill Passed - House (36 - 32)
Feb. 24, 2023 VA SB 1188 Classifies Fentanyl as a "Weapons of Terrorism" and a Class 4 Felony Conference Report Adopted - House (50 - 42)
Feb. 17, 2023 VA SB 948 Authorizes Pharmacists to Administer Controlled Substances or Devices for Certain Infections for Adults 18 and Older Bill Passed - House (65 - 34)
Feb. 16, 2023 MD HB 279 Establishes a Prescription Drug Affordability Board Bill Passed - House (97 - 38)
Feb. 13, 2023 SD HB 1135 Establishes Transparency in the Pricing of Prescription Drugs Bill Passed - House (62 - 5)
Jan. 11, 2023 MT HB 71 Amends State Alcohol Laws Bill Passed - House (95 - 3)
Date No. Title Outcome
12/13 SB 683 Requires Fentanyl and Xylazine Screening in Many Diagnostic Urine Tests Bill Passed - House (166 - 37)
12/12 HR 4531 Support for Patients and Communities Reauthorization Act Bill Passed - House (386 - 37)
10/05 SB 179 Authorizes Native American Tribes and the State to Form Individual Regulations and Taxes for Cannabis Bill Passed - House (91 - 15)
9/19 SB 189 Amends Legal Classification and Penalties for Crimes Related to Fentanyl Distribution Bill Passed - House (81 - 20)
9/12 SB 326 Authorizes Counties to Provide Substance Abuse Disorder Treatment that Emphasizes Housing Bill Passed - House (68 - 7)
9/06 SB 58 Amends Laws and Statutes Concerning the Decriminalization of Certain Hallucinogens Bill Passed - House (43 - 15)
6/30 S 1615 Establishes an Independent Board of Experts to Guide the State on Prescription Drug Policy Bill Passed - House (55 - 20)
6/24 HB 2395 Authorizes Specified Persons to Distribute and Administer Short-Acting Opioid Reversal Drugs and Kits Concurrence Vote Passed - House (46 - 3)
6/08 HB 90 Increases Penalties for Drug Distribution Resulting in Death to Life in Prison Conference Report Adopted - House (78 - 19)
6/05 SB 277 Expands the Amount of Legal Cannabis Individual's Can Possess Bill Passed - House (28 - 14)
6/03 AB 322 Establishes Regulations for Kratom Usage and Possession Bill Passed - House (30 - 12)
5/31 SB 49 Establishes New Penalties for the Operation of a Fentanyl Producing Laboratory Bill Passed - House (93 - 4)
5/31 AB 232 Establishes New Rules Regarding Premium Tobacco Products Bill Passed - House (35 - 7)
5/29 SB 35 Increases Criminal Penalties for Fentanyl Trafficking and Possession Bill Passed - House (31 - 10)
5/26 SB 437 Authorizes the Oklahoma Medical Marijuana Authority to Select a Vendor for Seed-to-Sale Inventory Tracking Concurrence Vote Passed - House (72 - 20)
5/25 SB 1043 Requires Hospitals to Provide Narcan Bill Passed - House (44 - 10)
5/25 HR 467 HALT Fentanyl Act Bill Passed - House (289 - 133)
5/25 AB 461 Requires Fentanyl Test Strips and Education about Use on College Campuses Bill Passed - House (78 - 0)
5/23 HB 286 Authorizes Expungements for Certain Amounts of Possession of Marijuana Bill Passed - House (69 - 30)
5/17 SF 2744 Establishes New Protections Over Prescription Drug Costs Conference Report Adopted - House (69 - 59)
5/16 SB 5536 Establishes Possession of a Controlled Substance as a Gross Misdemeanor (83 - 13)
5/16 HB 112 Amends Requirements for Epinephrine Prescription Bill Passed - House (36 - 4)
5/12 HB 202 Amends State Industrial Hemp Regulations Concurrence Vote Passed - House (105 - 47)
4/27 SB 8 Authorizes Pharmacy Benefit Managers to Negotiate Prices for Drugs Conference Report Adopted - House (72 - 21)
4/26 SB 442 Authorizes Counties to Use of 20% of Cannabis Revenues for Construction and Repair of Rural Roads Bill Passed - House (82 - 17)
4/25 HF 100 Establishes Cannabis Policy and Finances Bill Passed - House (71 - 59)
4/25 AB 250 Reduces Prescription Drug Costs by Expanding Policies Under the Federal Inflation Reduction Act Bill Passed - House (27 - 15)
4/13 HB 2513 Requires the Oregon Health Authority Carry Out State Voter Approved Drug Decriminalization Law Bill Passed - House (49 - 3)
4/12 SB 903 Authorizes New Limits on the THC Amount in Hemp Products Concurrence Vote Passed - House (52 - 41)
4/12 SB 1337 Establishes New Regulations and Provisions to the Medical Marijuana Program Concurrence Vote Passed - House (74 - 20)
4/12 SB 1533 Requires the Board of Pharmacy Consider Certain Factors when Determining Additional Cultivation Locations Concurrence Vote Passed - House (78 - 16)
4/12 SB 5069 Authorizes Interstate Cannabis Agreements Bill Passed - House (71 - 26)
4/10 SB 516 Authorizes an Independent Maryland Cannabis Administration Bill Passed - House (102 - 35)
4/08 HB 556 Requires Legalization of Recreational Cannabis by July 1, 2023 Concurrence Vote Passed - House (104 - 35)
4/07 SB 174 Exempts and Decriminalizes Fentanyl Testing Strips from the List of Drug Paraphernalia Conference Report Adopted - House (113 - 9)
4/06 HB 639 Authorizes Adults 21 and Older to Possess up to 4 Ounces of Cannabis Bill Passed - House (272 - 109)
3/30 SB 47 Establishes Legal Medical Cannabis Bill Passed - House (66 - 33)
3/29 HB 557 Authorizes Certain Physicians to Prescribe Schedule 2 Controlled Subtances Concurrence Vote Passed - House (173 - 2)
3/21 HF 595 Increases Penalties for the Manufacture, Distribution and Possession of Drugs Containing Fentanyl Bill Passed - House (91 - 3)
3/17 SB 51 Authorizes Cost-Sharing Contributions for Prescription Drug Bill Passed - House (44 - 21)
3/10 SB 220 Establishes the Industrial Hemp Development Act Bill Passed - House (92 - 4)
3/09 HB 2 Establishes State Regulations and Taxes for Recreational Cannabis Bill Passed - House (27 - 13)
3/07 HB 1 Authorizes Recreational Cannabis Use for Adults 21 and Older Bill Passed - House (28 - 13)
3/06 SB 1 Expands Definition of Who Can Access Medical Marijuana Program Bill Passed - House (36 - 32)
3/06 SB 1 Expands Definition of Who Can Access Medical Marijuana Program Bill Passed - House (36 - 32)
2/24 SB 1188 Classifies Fentanyl as a "Weapons of Terrorism" and a Class 4 Felony Conference Report Adopted - House (50 - 42)
2/17 SB 948 Authorizes Pharmacists to Administer Controlled Substances or Devices for Certain Infections for Adults 18 and Older Bill Passed - House (65 - 34)
2/16 HB 279 Establishes a Prescription Drug Affordability Board Bill Passed - House (97 - 38)
2/13 HB 1135 Establishes Transparency in the Pricing of Prescription Drugs Bill Passed - House (62 - 5)
1/11 HB 71 Amends State Alcohol Laws Bill Passed - House (95 - 3)

arrow_upward